Skip to main content

Psoriasis Comorbidities Content

News
Findings from a recent study showed the potential role of lectinlike oxidized low-density lipoprotein receptor-1 (LOX-1) in noncalcified coronary burden among patients with psoriasis.
News
A recent study investigated the ability of elastography and ultrasound for assessing the presence of liver steatosis and liver fibrosis among patients with psoriasis.
News
Findings from a recent study suggest the risk of end-stage renal disease is elevated among patients with psoriasis but is modified by systemic treatment use and the presence of arthritis.
News
A recent study investigated the impact of psoriasis on sexual function and psychological health among patients with psoriasis and their partners.
News
Findings from a recent study showed a strong association between psoriasis and hidradenitis suppurativa.
News
A recent study investigated the risk of major cardiovascular events among patients with psoriasis treated with various biologics and methotrexate.
News
Findings from a recent study showed elevated risk for cancer incidence and cancer-related mortality among patients with psoriasis, including various site-specific cancers such as pancreatic cancer.
News
A recent study showed bidirectional associations between psoriasis and inflammatory bowel disease, which suggests clinicians should consider evaluating for these conditions in their patients with psoriasis or IBD.
NPF Endorsed Features, Partners
Peter Sonnenreich; Bassem Wolley; and Katherine Moody, Contributing Writers
Certain comorbidities—particularly congestive heart failure, tuberculosis, and HIV infection—can affect the type of psoriasis treatment physicians recommend to their patients.
Features
Jill Waldbieser, Managing Editor
The association between psoriasis and cardiovascular risk has been well established, yet screening and management still lags behind. Here is what dermatologists should know.
Back to Top